3 Penny Stocks to Add to Your Watchlist Right Now
If you’re looking for the best penny stocks to buy, there are hundreds of options to choose from. And with a rather positive day of trading for penny stocks and blue chips, the market is ripe with opportunity. But, trading penny stocks is all about understanding exactly what is going on in the stock market.
And right now, the amount of momentum in the stock market means that this is more important than ever. As May comes to an end, the most crucial factors that are impacting the stock market are rising inflation rates, climbing interest, and geopolitical issues. All of this has created a highly volatile and reactive stock market that investors can take advantage of if they know what they’re doing.
For those who don’t know, penny stocks are shares that are worth less than $5 each. Because of this, they most of the time will be more volatile than their blue chip counterparts. But, this does not mean that there is no opportunity for profits. Rather, it provides more risk but also more potential reward. And with the right analysis and understanding, penny stocks can provide solid returns to investors.
However, it’s important to remember that penny stocks are a highly speculative investment. This means that you should never invest more than you can afford to lose. With this in mind, let’s take a look at three penny stocks to watch as May comes to an end.
3 Penny Stocks to Watch as May 2022 Ends
Regulus Therapeutics Inc. (NASDAQ: RGLS)
One of the larger gainers of the day is RGLS stock, which managed to push up by over 9% at EOD on May 23rd. And in the past five days, shares of RGLS stock have climbed by over 25%, which is no small feat. To understand why shares of RGLS stock are climbing, we have to take a look at its recent announcements and updates.
The most recent announcement from RGLS stock came on May 17th when it announced that its CEO and President, Jay Hagan, will be presenting at the H.C. Wainwright Global Investment Conference. If you’re not familiar, Regulus Therapeutics is a biopharmaceutical company working on discovering and developing new medicines. These medicines are used in microRNAs and the company overall is working on pipelines for its oligonucleotide drug discovery program.
And only a few days before it, the company announced the acceptance of its IND from the FDA regarding its RGLS8429 for treating autosomal dominant polycystic kidney disease. All of this has made the company more popular in the past two weeks than it has been prior. Considering this, will it be on your list of penny stocks to watch or not?
Nerdy Inc. (NYSE: NRDY)
During trading and into after hours, shares of NRDY stock managed to climb by more than 17% and 5% respectively. To understand why shares are climbing, we have to take a look at what the company does and what it has been up to recently. Nerdy is a platform that allows for online learning utilizing technology. The company offers a large range of learning experiences with over 3,000 subjects and formats.
This includes self-study, large format group classes and much more. The most recent news from the company came on May 20th. On the 20th, the company announced a collaboration with the Smithsonian Institution. This collaboration will offer people around the world access to content from the Smithsonian. And, it will kick off with a group online class hosted on May 24th at 7 P.M.
“The Smithsonian is renowned for its amazing collections and world-class content, and it’s a true privilege to be sharing a front row seat with learners everywhere.
Over the past two years, our StarCourse series has attracted everyday learners from around the world, and continues to be among our most popular content. The class headlined by the Smithsonian is expected to draw huge audiences, hungry to learn more about Paleontology. We look forward to feeding their curiosity.”The Chief Academic Officer at Nerdy, Brian Galvin
With this in mind, will NRDY be on your penny stocks watchlist this month?
Aethlon Medical Inc. (NASDAQ: AEMD)
Last on the list of sizable gainers on May 23rd is AEMD stock. By EOD, shares of AEMD had pushed up by more than 22%, putting it at over $1.60 per share. And in the past five days, we’ve seen shares of AEMD stock climb by more than 45%, which is no small feat. Part of the reason behind this gain comes as we have seen sizable bullish momentum in the biotech industry as of late.
And as a medical tech company, Aethlon has a role in several pressing issues. This includes its FDA designated, Hemopurifier device, which could be a major breakthrough for those with advanced or metastatic cancers. From May 23-26th, Aethlon will be participating in the H.C. Wainwright Global Investment Conference, which will be held in Miami. This is the next time we will hear from the company and what it has been up to. Whether this makes AEMD worth buying or not is up to you.
Which Penny Stocks Are You Buying Right Now?
If you’re looking or the best penny stocks to buy as May comes to an end, there are quite a lot to choose from. But, just because there are plenty of options, does not mean that they are all worth buying.
[Read More] Penny Stocks To Buy Now? 4 To Watch Under $1
Rather, investors need to have a full understanding of what is going on in the stock market and how to take advantage. With that in mind, which penny stocks are you watching right now?